Skip to content

PERsonalized Mood Augmentation Trial for Depressed Mood

PERsonalized Mood Augmentation Trial for Depressed Mood

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05662254
Acronym
PERMA
Enrollment
40
Registered
2022-12-22
Start date
2022-06-01
Completion date
2024-10-11
Last updated
2025-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Brief summary

The goal of this open-label single-arm study is to test personalized behavioral intervention for depressed mood.

Detailed description

The goal of this open-label single-arm study is to test personalized behavioral intervention for depressed mood. After an initial period (2-4 weeks) of mood and lifestyle monitoring using smartphone and smartwatch data, participants will be assigned to an evidenced-based behavioral plan that target their lifestyle for 6 weeks. The trial will evaluate changes in depressed mood, associated health behaviors and cognition.

Interventions

Behavioral lifestyle intervention assigned according to each participant's mood and lifestyle data patterns.

Sponsors

University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Mild to moderate depression per PHQ9 symptom ratings

Exclusion criteria

* active substance abuse/dependence * psychotic disorders * bipolar disorder * eating disorder * displaying acutely suicidal behaviors

Design outcomes

Primary

MeasureTime frameDescription
PHQ912 weeksDepression Symptoms on the Patient Health Questionnaire 9-item (PHQ9) scale, min 0 max 27 with lower scores representing better outcome

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 20, 2026